TheNote.app
Sign In
Sign Up
RSS European Medicines Agency (EMA) | What's new
Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Date of authorisation: 03/08/2001, Revision: 37, Status: Authorised
www.ema.europa.eu
www.ema.europa.eu
